List of Monoclonal Antobodies
• Abciximab ReoPro 1994 chimeric inhibition of glycoprotein IIb/IIIa Cardiovascular disease
• Infliximab chimeric I inhibition of TNF-a Inflammatory diseases
.Adalimumab human inhibition of TNF-a signalling Inflammatory diseases
• Natalizumab humanized T cell VLA4 receptor Inflammatory diseases . (esp autoimmune-related multiple sclerosis therapy)
• Omalizumab humanized Ig E Inflammatory diseases . (mainly allergy-related asthma therapy)
• Eculizumab humanized complement C5 Inflammatory diseases . (PNH)
• Efalizumab humanized CD11a Inflammatory diseases . (psoriasis)
• Alemtuzumab humanized CD52 CLL
Gemtuzumab humanized CD33 AML . (with calicheamicin)
• Ri - tuximab Rituxan, chimeric CD20 NHL
Ibritumomab tiuxetan murine CD20 NHL (with yttrium-90 or indium-111)
Tostumomab murine CD20 NHL
.Daclizumab humanized IL-2 receptor Transplant rejection
Basiliximab chimeric IL-2 receptor Transplant rejection
Muromonab murine CD3 Receptor Transplant rejection
• Bevaciz umab humanized vascular endothelial growth factor Colorectal cancer
Panitumumab human epidermal growth factor receptor Colorectal cancer
Cetuximab chimeric epidermal growth factor receptor Colorectal cancer
• Ranibizumab humanized vascular endothelial growth factor Macular degeneration
• Palivizumab humanized epitope of F protein of RSV Viral infection (espRSV)
• Trastuzumab humanized ErbB2 Breast cancer
-mab suffix monoclonal antibody.
if immediately before mab----u--its humane derived
. ---mo--its murine
. ----i----its chimeric.
No comments:
Post a Comment